Latest Microarrays Stories
HAMBURG, Germany, January 18, 2012 /PRNewswire/ -- Eppendorf AG has licensed patents covering gradient technology for thermal cyclers to Bibby Scientific for use e.g. in their TC Plus Thermal Cyclers, including US patent Nos. 6,767,512 and 7,074,367. Eppendorf utilizes the technology in its Eppendorf Mastercycler(R) pro gradient, Mastercycler nexus gradient and Mastercycler ep realplex models. Eppendorf AG, based in Hamburg, Germany, develops, produces and distributes...
Two different U.S. companies have announced plans to release equipment that can sequence an individual's genome in a single day, with both machines being revealed to the public within hours of each other on Tuesday. The first to announce their genome-sequencing machine was Ion Torrent, a Connecticut-based division of the Life Technologies Corporation, according to Reuters and Associated Press (AP) reports. The company, which claims that its Ion Proton Sequencer is 1,000 times more...
IRVINE, Calif. and AMSTERDAM, Jan. 9, 2012 /PRNewswire/ -- Agendia, an innovative molecular cancer diagnostics company, today announced that Peter C. Wulff has joined the company as Vice President of Finance and Chief Financial Officer. Wulff is responsible for all aspects of the company's global finance function. "We are very pleased to bring Peter Wulff onto our executive team as Vice President of Finance and Chief Financial Officer," said David Macdonald, CEO of Agendia. "Peter...
IRVINE, Calif. and AMSTERDAM, Jan. 5, 2012 /PRNewswire/ -- Agendia, an innovative molecular cancer diagnostics company, today announced that the company has signed a contract with Blue Shield of California, making Agendia an in-network provider. The move paves the way for future in-network coverage for MammaPrint® and other Agendia tests by Blue Cross affiliates across the United States. Developed and commercialized by Agendia, MammaPrint is the keystone of the company's...
FREMONT, Calif., Jan. 5, 2012 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that the company plans to deliver its corporate presentation at the 5(th) Annual OneMedForum San Francisco 2012, at the Sir Francis Drake Hotel, San Francisco, Calif., January 9-12, 2012. The company is scheduled to present on Tuesday, January 10, 2012 beginning at 10:00 a.m. Pacific Time. The presentation will be available live and for...
Upcoming webinar showcases a new genotyping-by-sequencing (GBS) method enabled by Innovadyne Liquid Handler. (PRWEB) December 27, 2011 In cooperation with Cornell University, IDEX Health & Science debuts a new-method webinar describing a streamlined genotyping technology developed at Cornell’s Institute for Genomic Diversity (IGD). Titled “An Efficient New Genotyping-By-Sequencing Method for Highly Diverse Species”, the webinar explains how the new GBS method allows Cornell...
ALISO VIEJO, Calif., Dec. 21, 2011 /PRNewswire/ -- Ambry Genetics, a global leader in clinical diagnostics and genomic services, announced today that they have officially launched their Illumina MiSeq Next-Gen sequencing services. Ambry Genetics has been an early adapter of Illumina sequencing systems since 2007 and has extensive experience as a Certified Service Provider processing thousands of samples. (Logo: http://photos.prnewswire.com/prnh/20110307/LA59848LOGO) The Illumina...
Speed can save lives – especially in the case of blood poisoning. The more quickly and directly doctors recognize and treat sepsis, the greater the patient’s chances of survival. With the help of a new biochip, physicians will now be able to analyze blood within their own practice. Is the patient suffering from blood poisoning? To answer this question, the doctor draws a blood sample and sends it to a central laboratory for testing. This takes up valuable time, which could cost the...
FREMONT, Calif., Dec. 8, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that the company plans to deliver its corporate presentation at the Oppenheimer 22nd Annual Healthcare Conference at the Waldorf-Astoria, New York, NY, December 13-14, 2011. The Company is scheduled to present on Tuesday, December 13, 2011 from 3:35-3:50 p.m. Eastern Time. The presentation will be webcast live and will be available for...
